Thibaut Mongon has departed as chief govt officer of Kenvue and stepped down from the board.
Kirk Perry has been named interim CEO, efficient instantly, because the board conducts a seek for Mongon’s everlasting successor, the corporate mentioned Monday.
Perry is a present Kenvue director and seasoned shopper merchandise and model strategist with greater than 30 years of expertise.
Of his appointment, Larry Merlo, Kenvue’s chair of the board, mentioned: “We’re very happy to have a frontrunner of Kirk’s caliber and expertise step into the function of interim CEO to steer Kenvue throughout this necessary time. His deep data of the intersection of know-how, knowledge and international shoppers has already been an asset throughout his time on the board and we sit up for Kenvue persevering with to learn from his experience and management on this further function. On behalf of the board, I need to thank Thibaut for his oversight in establishing Kenvue as a stand-alone firm and for his dedication to the group all through his tenure.”
Perry added: “I’m excited to leverage my a long time of expertise main companies throughout the buyer and know-how industries and work with the board and management workforce to place the enterprise on the strongest footing to ship on Kenvue’s full potential and understand our aim of top-tier monetary efficiency.”
The CEO change comes because the board is finishing up a strategic evaluation “to unlock shareholder worth and attain its full potential,” together with assessing its present portfolio.
Kenvue was spun out of Johnson & Johnson in 2023. Its manufacturers embrace Neutrogena, Aveeno, OGX and Tylenol.
“Kenvue has world-class manufacturers in engaging classes and a powerful international platform. The actions introduced at present are to make sure we now have the suitable expertise, model portfolio and operational basis to completely capitalize on these strengths, speed up worthwhile progress and greatest place the corporate for future success,” mentioned Merlo. “The board’s strategic evaluation is underway, and we’re contemplating a broad vary of potential alternate options, together with methods to simplify the corporate’s portfolio and the way it operates.”
Its share worth closed up 2.18 % at $21.82 on Monday.
